Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-05-15
2007-05-15
Keys, Rosalynd (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S651000, C564S347000, C564S348000
Reexamination Certificate
active
11109046
ABSTRACT:
The present invention provides 8-(2-hydroxyphenoxy)octyldiethanolamine) and salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same. The delivery agents of the present invention are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.
REFERENCES:
patent: 5401516 (1995-03-01), Milstein et al.
patent: 5443841 (1995-08-01), Milstein et al.
patent: 5629020 (1997-05-01), Leone-Bay et al.
patent: 5643957 (1997-07-01), Leone-Bay et al.
patent: 5766633 (1998-06-01), Milstein et al.
patent: RE35862 (1998-07-01), Steiner et al.
patent: 5776888 (1998-07-01), Leone-Bay et al.
patent: 5866536 (1999-02-01), Leone-Bay et al.
patent: WO 00/40203 (2000-07-01), None
patent: WO 00/50386 (2000-08-01), None
patent: WO 00/59863 (2000-10-01), None
patent: WO 01/32130 (2001-05-01), None
patent: WO 01/32596 (2001-05-01), None
patent: WO/03/045306 (2003-06-01), None
patent: WO 03/045306 (2003-06-01), None
patent: WO 03/045331 (2003-06-01), None
Brown, et al., “The role of bisphosphonates in breast and prostate cancers”, Endocrine-Related Cancer, vol. 11: pp. 207-224*(2004).
P. Major, “The Use of Zoledronic Acid, a Novel, Highly Potent Bisphosphonate, for the Treatment of the Hypercalcemia of Malignancy”, The Oncologist, vol. 7: pp. 481-491*(2002).
Tripathy, et al., “Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial”, Annals of Oncology, vol. 15: pp. 743-750 (Jan. 2004).
R. Coleman, “Management of Bone Metastases”, The Oncologist, vol. 5: pp. 463-470 (Sep. 2000).
Boissier, et al., “Bisphosphonates Inhibit Breast and Prostate Carcinoma Cell Invasion, an Early Event in the Formation of Bone Metastates”, Cancer Research, vol. 60: pp. 2949-2954 (Jun. 2000).
E. Jantunen, “Bisphosphonate therapy in multiple myeloma: past, present, future”, European Journal of Haematology, vol. 9: pp. 257-264 (2002).
Darby & Darby
Emisphere Technologies Inc.
Keys Rosalynd
LandOfFree
8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3787618